Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00257946 · ClinicalTrials.gov registry record · Phase 3

Type of Material in Repair of Congenital Diaphragmatic Hernia

A Phase 3 study, sponsored by Children's Mercy Hospital Kansas City.

Terminated
Registry status
Phase 3
Development phase
50
Enrollment target

NCT00257946: Clinical Trial Phase 3 study, sponsored by Children's Mercy Hospital Kansas City.

NCT00257946 is a Phase 3 study that was terminated before completion, run by Children's Mercy Hospital Kansas City. The registered enrollment target is 50 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00257946, a Phase 3 study, was terminated before completion, sponsored by Children's Mercy Hospital Kansas City.

TERMINATED
Registry status
Phase 3
Development phase
50 participants
Enrollment target

Study Summary

The objective of this study is to evaluate the use of 2 different types of biosynthetic material for the repair of congenital diaphragmatic hernia. The research question is: what is the best material for repairing large congenital diaphragmatic hernias? The primary outcome variable is recurrence.

Interventions

  • PROCEDURE Repair of CDH w/SIS Gold
  • PROCEDURE Repair of CDH w/Alloderm

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2005-12
Est. Completion 2007-08
Phase Phase 3

Why NCT00257946 stopped before completion

NCT00257946 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (94% lower).

The record links to 0 conditions, and to 2 interventions - of which Repair of CDH w/SIS Gold is the first listed.

NCT00257946 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00257946 about?

NCT00257946 is a clinical study titled "Type of Material in Repair of Congenital Diaphragmatic Hernia". The objective of this study is to evaluate the use of 2 different types of biosynthetic material for the repair of congenital diaphragmatic hernia. The research question is: what is the best material for repairing large congenital diaphragmatic hernias? The primary outcome variable is recurrence.

What is the current status of trial NCT00257946?

This trial is currently terminated. It is a Phase 3 study. The enrollment target is 50 participants. The study started on 2005-12. Estimated completion is 2007-08.

What interventions are being tested in trial NCT00257946?

The interventions under investigation include: Repair of CDH w/SIS Gold (PROCEDURE), Repair of CDH w/Alloderm (PROCEDURE).

Who is sponsoring clinical trial NCT00257946?

This trial is sponsored by Children's Mercy Hospital Kansas City, which has 184 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00257946's enrollment target sits among peer trials

50 1844th of 2000 higher than 141 of 2,000 other Phase 3 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00257946, the US trial registry maintained by the National Library of Medicine. NCT00257946 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.